Sudden hearing loss in a melanoma patient on pembrolizumab: an etiology not to be omitted in the differential diagnosis
Crossref DOI link: https://doi.org/10.1186/s40425-017-0226-5
Published Online: 2017-03-21
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nader, Marc-Elie https://orcid.org/0000-0001-9295-0174
Myers, Jeffrey N.
Gidley, Paul W.